Statistics
Publications
19
Citations
5K
H-Index
18
Active since
2000
Mark Heise is an author at GlaxoSmithKline (United States) specializing in medicine, diabetes mellitus, and clinical pharmacology.
Publications per year
2000–2024
19
19
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Steven E. Kahn, Steven M. Haffner, Mark Heise et al. · New England Journal of Medicine · 2006 · 2.9K citations
Rosiglitazone-Associated Fractures in Type 2 Diabetes
Steven E. Kahn, Bernard Zinman, John M. Lachin et al. · Diabetes Care · 2008 · 537 citations · Full text
A Diabetes Outcome Progression Trial (ADOPT)
Giancarlo Viberti, Steven E. Kahn, Douglas A. Greene et al. · Diabetes Care · 2002 · 272 citations · Full text
Rosiglitazone reduces urinary albumin excretion in type II diabetes
George L. Bakris, Giancarlo Viberti, Wayde M. Weston et al. · Journal of Human Hypertension · 2003 · 240 citations
1–5 of 19